GELS
Gelteq Limited Ordinary Shares
NASDAQ: GELS · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.66
+2.00% today
Updated 2026-05-01
Market cap
$6.91M
P/E ratio
—
P/S ratio
16.72x
EPS (TTM)
$-0.52
Dividend yield
—
52W range
$1 – $4
Volume
0.0M
WallStSmart proprietary scores
33
out of 100
Grade: F
Strong Sell
Investment rating
6.0
Growth
B5.0
Quality
C+2.5
Profitability
F5.0
Valuation
C+4/9
Piotroski F-Score
Moderate
-0.5
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →204 stocks currently score above 75
Price targets
Analyst target
$—
—
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
+ Revenue growth 59.40% QoQ
+ Debt/equity 0.27x — low leverage
Risks
- Altman Z -0.46 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-6.16M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $147536.00 | $79843.00 | $0.00 | $165645.00 | $413130.00 |
| Net income | $-3.37M | $-3.51M | $-3.55M | $-6.65M | $-6.65M |
| EPS | — | — | — | — | $-0.52 |
| Free cash flow | — | $-1.85M | $-1.22M | $-6.16M | $-6.16M |
| Profit margin | -2,283.44% | -4,391.39% | — | -4,011.86% | — |
Peer comparison
Smart narrative
Gelteq Limited Ordinary Shares trades at $0.66. Our Smart Value Score of 33/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of -0.46, it sits in the distress. TTM revenue stands at $413130.00.
Frequently asked questions
What is Gelteq Limited Ordinary Shares's stock price?
Gelteq Limited Ordinary Shares (GELS) trades at $0.66.
Is Gelteq Limited Ordinary Shares overvalued?
Smart Value Score 33/100 (Grade F, Strong Sell).
What is the price target of Gelteq Limited Ordinary Shares (GELS)?
The analyst target price is $—, representing NaN% downside from the current price of $0.66.
What is Gelteq Limited Ordinary Shares's revenue?
TTM revenue is $413130.00.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
-0.46 — distress.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio16.72x
ROE-43.00%
Beta—
50D MA$0.73
200D MA$1.08
Shares out0.01B
Float0.00B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—